Vertex Suffers Setback In Its Search For Post-CF Blockbusters

Analysts Doubt Pipeline Potential

 
• By Andrew McConaghie

Vertex has become a biotech investor favorite amid the tumult of 2020, but the potential of its pipeline is now under question.

Vertex Corporate Headquarters
Vertex's shares were up 25% this year before the news of the pipeline setback. • Source: Vertex

More from Business

More from Scrip